• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

声铬罗莫烷可改善与 iPSC 衍生神经元中 m.3243A>G 异质型相关的神经元网络功能障碍和转录组变化。

Sonlicromanol improves neuronal network dysfunction and transcriptome changes linked to m.3243A>G heteroplasmy in iPSC-derived neurons.

机构信息

Department of Medical Imaging, Anatomie, Radboud University Medical Center, Geert Grooteplein 10, Nijmegen, 6525 GA, the Netherlands; Department of Human Genetics, Radboudumc, Donders Institute for Brain, Cognition, and Behaviour, Nijmegen, 6500 HB, the Netherlands.

Department of Human Genetics, Radboudumc, Donders Institute for Brain, Cognition, and Behaviour, Nijmegen, 6500 HB, the Netherlands; Centre for Molecular and Biomolecular Informatics, Radboudumc, Nijmegen, the Netherlands.

出版信息

Stem Cell Reports. 2021 Sep 14;16(9):2197-2212. doi: 10.1016/j.stemcr.2021.07.002. Epub 2021 Jul 29.

DOI:10.1016/j.stemcr.2021.07.002
PMID:34329596
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8452519/
Abstract

Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) is often caused by an adenine to guanine variant at m.3243 (m.3243A>G) of the MT-TL1 gene. To understand how this pathogenic variant affects the nervous system, we differentiated human induced pluripotent stem cells (iPSCs) into excitatory neurons with normal (low heteroplasmy) and impaired (high heteroplasmy) mitochondrial function from MELAS patients with the m.3243A>G pathogenic variant. We combined micro-electrode array (MEA) measurements with RNA sequencing (MEA-seq) and found reduced expression of genes involved in mitochondrial respiration and presynaptic function, as well as non-cell autonomous processes in co-cultured astrocytes. Finally, we show that the clinical phase II drug sonlicromanol can improve neuronal network activity when treatment is initiated early in development. This was intricately linked with changes in the neuronal transcriptome. Overall, we provide insight in transcriptomic changes in iPSC-derived neurons with high m.3243A>G heteroplasmy, and show the pathology is partially reversible by sonlicromanol.

摘要

线粒体脑肌病、乳酸酸中毒和卒中样发作(MELAS)通常是由 MT-TL1 基因 m.3243(m.3243A>G)处的腺嘌呤到鸟嘌呤变异引起的。为了了解这种致病变异如何影响神经系统,我们从携带 m.3243A>G 致病变异的 MELAS 患者中分化出具有正常(低异质性)和受损(高异质性)线粒体功能的兴奋性神经元。我们将微电极阵列(MEA)测量与 RNA 测序(MEA-seq)相结合,发现与线粒体呼吸和突触前功能相关的基因表达降低,以及共培养的星形胶质细胞中的非细胞自主过程。最后,我们表明,临床二期药物 sonlicromanol 可以在早期发育时通过改变神经元转录组来改善神经元网络活动。这与神经元转录组的变化密切相关。总的来说,我们提供了高 m.3243A>G 异质性的 iPSC 衍生神经元中转录组变化的见解,并表明 sonlicromanol 可部分逆转病变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c91/8452519/8f93ecbd779a/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c91/8452519/986a9a775dfb/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c91/8452519/0601056deabd/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c91/8452519/7127876a6c00/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c91/8452519/84ae5993818f/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c91/8452519/6327e6f212aa/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c91/8452519/8f93ecbd779a/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c91/8452519/986a9a775dfb/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c91/8452519/0601056deabd/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c91/8452519/7127876a6c00/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c91/8452519/84ae5993818f/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c91/8452519/6327e6f212aa/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c91/8452519/8f93ecbd779a/gr6.jpg

相似文献

1
Sonlicromanol improves neuronal network dysfunction and transcriptome changes linked to m.3243A>G heteroplasmy in iPSC-derived neurons.声铬罗莫烷可改善与 iPSC 衍生神经元中 m.3243A>G 异质型相关的神经元网络功能障碍和转录组变化。
Stem Cell Reports. 2021 Sep 14;16(9):2197-2212. doi: 10.1016/j.stemcr.2021.07.002. Epub 2021 Jul 29.
2
T cell activation contributes to purifying selection against the MELAS-associated m.3243A>G pathogenic variant in blood.T 细胞的激活有助于对血液中与 MELAS 相关的 m.3243A>G 致病性变异体进行清除选择。
J Inherit Metab Dis. 2024 Jul;47(4):757-765. doi: 10.1002/jimd.12726. Epub 2024 Mar 18.
3
Heteroplasmy and phenotype spectrum of the mitochondrial tRNA gene m.3243A>G mutation in seven Han Chinese families.七个汉族家系中线粒体 tRNA 基因 m.3243A>G 突变的异质性和表型谱。
J Neurol Sci. 2020 Jan 15;408:116562. doi: 10.1016/j.jns.2019.116562. Epub 2019 Nov 6.
4
m.3243A > G-Induced Mitochondrial Dysfunction Impairs Human Neuronal Development and Reduces Neuronal Network Activity and Synchronicity.m.3243A>G诱导的线粒体功能障碍损害人类神经元发育并降低神经元网络活性和同步性。
Cell Rep. 2020 Apr 21;31(3):107538. doi: 10.1016/j.celrep.2020.107538.
5
The MELAS mutation m.3243A>G promotes reactivation of fetal cardiac genes and an epithelial-mesenchymal transition-like program via dysregulation of miRNAs.MELAS 突变 m.3243A>G 通过 miRNA 失调促进胎儿心脏基因的重新激活和上皮-间充质转化样程序。
Biochim Biophys Acta Mol Basis Dis. 2018 Sep;1864(9 Pt B):3022-3037. doi: 10.1016/j.bbadis.2018.06.014. Epub 2018 Jun 19.
6
Disease-causing mitochondrial heteroplasmy segregated within induced pluripotent stem cell clones derived from a patient with MELAS.由 MELAS 患者诱导多能干细胞克隆中分离出的致病线粒体异质性。
Stem Cells. 2013 Jul;31(7):1298-308. doi: 10.1002/stem.1389.
7
Modeling of mitochondrial bioenergetics and autophagy impairment in MELAS-mutant iPSC-derived retinal pigment epithelial cells.MELAS 突变型 iPSC 衍生的视网膜色素上皮细胞中线粒体生物能量和自噬损伤的建模。
Stem Cell Res Ther. 2022 Jun 17;13(1):260. doi: 10.1186/s13287-022-02937-6.
8
Impaired respiratory function in MELAS-induced pluripotent stem cells with high heteroplasmy levels.高异质性水平的MELAS诱导多能干细胞中呼吸功能受损。
FEBS Open Bio. 2015 Mar 20;5:219-25. doi: 10.1016/j.fob.2015.03.008. eCollection 2015.
9
Detection rates and phenotypic spectrum of m.3243A>G in the MT-TL1 gene: a molecular diagnostic laboratory perspective.MT-TL1 基因 m.3243A>G 的检测率及表型谱:分子诊断实验室视角。
Mitochondrion. 2014 Jul;17:34-41. doi: 10.1016/j.mito.2014.05.005. Epub 2014 May 17.
10
Establishment of variant free-iPSC (UOMi003-A) line from patient with mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes.从患有线粒体脑肌病、乳酸酸中毒和类似中风发作的患者中建立无变体 iPSC(UOMi003-A)系。
Stem Cell Res. 2020 Oct;48:101935. doi: 10.1016/j.scr.2020.101935. Epub 2020 Aug 3.

引用本文的文献

1
Peptide-mimetics derived from leucyl-tRNA synthetase are potential agents for the therapy of mt-tRNA related diseases.源自亮氨酰 - tRNA合成酶的肽模拟物是治疗线粒体tRNA相关疾病的潜在药物。
Front Pharmacol. 2025 Jul 28;16:1607343. doi: 10.3389/fphar.2025.1607343. eCollection 2025.
2
Automated inference of disease mechanisms in patient-hiPSC-derived neuronal networks.患者诱导多能干细胞衍生神经网络中疾病机制的自动推断
Commun Biol. 2025 May 20;8(1):768. doi: 10.1038/s42003-025-08209-2.
3
Mitochondrial diseases: from molecular mechanisms to therapeutic advances.

本文引用的文献

1
Cadherin-13 is a critical regulator of GABAergic modulation in human stem-cell-derived neuronal networks.钙黏蛋白 13 是人类干细胞源性神经元网络中 GABA 能调制的关键调节因子。
Mol Psychiatry. 2022 Jan;27(1):1-18. doi: 10.1038/s41380-021-01117-x. Epub 2021 May 10.
2
m.3243A > G-Induced Mitochondrial Dysfunction Impairs Human Neuronal Development and Reduces Neuronal Network Activity and Synchronicity.m.3243A>G诱导的线粒体功能障碍损害人类神经元发育并降低神经元网络活性和同步性。
Cell Rep. 2020 Apr 21;31(3):107538. doi: 10.1016/j.celrep.2020.107538.
3
Organoid cultures of MELAS neural cells reveal hyperactive Notch signaling that impacts neurodevelopment.
线粒体疾病:从分子机制到治疗进展
Signal Transduct Target Ther. 2025 Jan 10;10(1):9. doi: 10.1038/s41392-024-02044-3.
4
Phase 2b program with sonlicromanol in patients with mitochondrial disease due to m.3243A>G mutation.针对因m.3243A>G突变导致线粒体疾病患者开展的司尼铬醇2b期项目。
Brain. 2025 Mar 6;148(3):896-907. doi: 10.1093/brain/awae277.
5
Breaking the burst: Unveiling mechanisms behind fragmented network bursts in patient-derived neurons.打破爆发:揭示源自患者源性神经元中碎片化网络爆发的机制。
Stem Cell Reports. 2024 Nov 12;19(11):1583-1597. doi: 10.1016/j.stemcr.2024.09.001. Epub 2024 Oct 3.
6
Clinical Approaches for Mitochondrial Diseases.线粒体疾病的临床方法。
Cells. 2023 Oct 20;12(20):2494. doi: 10.3390/cells12202494.
7
The Mitochondrial m.3243A>G Mutation on the Dish, Lessons from In Vitro Models.线粒体 m.3243A>G 突变在体外模型中的启示。
Int J Mol Sci. 2023 Aug 30;24(17):13478. doi: 10.3390/ijms241713478.
8
Mitochondrial impairment and synaptic dysfunction are associated with neurological defects in iPSCs-derived cortical neurons of MERRF patients.线粒体功能障碍和突触功能障碍与 MERRF 患者诱导多能干细胞衍生皮质神经元的神经缺陷有关。
J Biomed Sci. 2023 Aug 21;30(1):70. doi: 10.1186/s12929-023-00966-8.
9
An in silico and in vitro human neuronal network model reveals cellular mechanisms beyond Na1.1 underlying Dravet syndrome.一种基于计算机的和在体的人类神经元网络模型揭示了 Dravet 综合征相关的 Na1.1 以外的细胞机制。
Stem Cell Reports. 2023 Aug 8;18(8):1686-1700. doi: 10.1016/j.stemcr.2023.06.003. Epub 2023 Jul 6.
10
Modeling mitochondrial DNA diseases: from base editing to pluripotent stem-cell-derived organoids.建模线粒体 DNA 疾病:从碱基编辑到多能干细胞衍生的类器官。
EMBO Rep. 2023 Apr 5;24(4):e55678. doi: 10.15252/embr.202255678. Epub 2023 Mar 6.
MELAS 神经细胞类器官培养物揭示了过度活跃的 Notch 信号传导,影响神经发育。
Cell Death Dis. 2020 Mar 13;11(3):182. doi: 10.1038/s41419-020-2383-6.
4
Effects of clofibrate and KH176 on life span and motor function in mitochondrial complex I-deficient mice.氯贝丁酯和 KH176 对线粒体复合体 I 缺陷小鼠寿命和运动功能的影响。
Biochim Biophys Acta Mol Basis Dis. 2020 Jun 1;1866(6):165727. doi: 10.1016/j.bbadis.2020.165727. Epub 2020 Feb 15.
5
Recent advances in understanding the molecular genetic basis of mitochondrial disease.近年来,人们对线粒体疾病的分子遗传基础有了更深入的了解。
J Inherit Metab Dis. 2020 Jan;43(1):36-50. doi: 10.1002/jimd.12104. Epub 2019 May 10.
6
Mitochondria, Metabolism, and Redox Mechanisms in Psychiatric Disorders.精神疾病中的线粒体、代谢和氧化还原机制。
Antioxid Redox Signal. 2019 Aug 1;31(4):275-317. doi: 10.1089/ars.2018.7606. Epub 2019 Feb 1.
7
The KHENERGY Study: Safety and Efficacy of KH176 in Mitochondrial m.3243A>G Spectrum Disorders.KHENERGY 研究:KH176 在线粒体 m.3243A>G 谱障碍中的安全性和疗效。
Clin Pharmacol Ther. 2019 Jan;105(1):101-111. doi: 10.1002/cpt.1197. Epub 2018 Sep 3.
8
Mitochondrial medicine in the omics era.组学时代的线粒体医学。
Lancet. 2018 Jun 23;391(10139):2560-2574. doi: 10.1016/S0140-6736(18)30727-X. Epub 2018 Jun 18.
9
KH176 Safeguards Mitochondrial Diseased Cells from Redox Stress-Induced Cell Death by Interacting with the Thioredoxin System/Peroxiredoxin Enzyme Machinery.KH176 通过与硫氧还蛋白系统/过氧化物酶酶机制相互作用,保护线粒体病变细胞免受氧化应激诱导的细胞死亡。
Sci Rep. 2018 Apr 26;8(1):6577. doi: 10.1038/s41598-018-24900-3.
10
KH176 under development for rare mitochondrial disease: a first in man randomized controlled clinical trial in healthy male volunteers.KH176 正在开发用于罕见的线粒体疾病:在健康男性志愿者中的首次人体随机对照临床试验。
Orphanet J Rare Dis. 2017 Oct 16;12(1):163. doi: 10.1186/s13023-017-0715-0.